What an amazing year we’ve had, thanks to our volunteers, donors and fundraisers!
Read our latest Impact Report for 2025/26 to find out how HEART UK’s work last year impacted the lives of thousands of people with high cholesterol and other blood fat conditions, their healthcare professionals, our communities and policies at national and local levels.
https://t.co/QvC9xvbyVs
The Economic Value of Detecting and Treating Familial Hypercholesterolaemia in the United Kingdom.
This report examines the health, economic and social value of improving how FH is detected and treated. The findings show that earlier diagnosis delivers substantial lifetime benefits, preventing avoidable illness and premature deaths, improving quality of life and providing significant value for both the NHS and wider society.
HEART UK is calling for investment to optimise and expand FH cascade testing now, alongside consideration of FH within future newborn screening programmes.
https://t.co/ftRzLYlOI2
Great to meet HEART UK, clinicians and patients at Stormont yesterday to learn more about cholesterol and Familial Hypercholesterolaemia (FH).
Early detection and simple lifestyle changes can save lives.
Cholesterol Matters. Every Swap Counts.
#NationalCholesterolMonth
@ColinSDLP A big thank you for attending and contributing to these valuable discussions. Together, we can improve awareness, diagnosis and treatment and help protect heart health across Northern Ireland.
@healthdpt A big thank you for attending and contributing to these valuable discussions. Together, we can improve awareness, diagnosis and treatment and help protect heart health across Northern Ireland.
💖 The Health Minister met with @heartukcharity clinicians and patients to learn more about cholesterol and Familial Hypercholesterolaemia (FH).
🙌 Minister Butler learned more about simple, healthy lifestyle swaps as part of National Cholesterol Month.
Cholesterol SMART® Living- helping patients put dietary advice into practice
Talking about dietary changes is one thing. Knowing what to cook when you get home can be another. Cholesterol SMART® Living is HEART UK’s new recipe service, designed to help people turn heart-healthy eating advice into tasty, practical everyday meals.
Find out more about Cholesterol SMART® Living - https://t.co/f3hhmb1kwW
#NCM
This National Cholesterol Month, we’re focusing on a simple message: Cholesterol Matters. Every Swap Counts.
Looking after your heart doesn’t have to mean making big changes all at once. Small, everyday swaps can add up – whether it’s choosing a heart-healthier option at mealtimes, moving a little more, or swapping an old habit for something that supports your wellbeing.
https://t.co/A3vHt9zeox
#NCM26
Today is #WorldHeartDay - a reminder to make heart health a priority.
We’re pleased to have partnered with @MediaplanetUK on the World Heart Day report, launched today, exploring innovations in cardiovascular medicine and the steps we can all take to help prevent cardiovascular disease (CVD).
Read more below or look out for a copy inside The Guardian today.
https://t.co/5Fk86jokQn
#WorldHeartDay26 #WorldHeartDay #DontMissABeat
Help your patients put heart-healthy eating advice into practice. Advising patients about dietary changes is one thing. Helping them put that advice into practice at home can be another.
Cholesterol SMART® Living is HEART UK’s dedicated recipe service, designed to help people turn heart-healthy eating advice into tasty, practical everyday meals.
Every recipe has been reviewed and approved by HEART UK dietitians, giving you a trusted resource that you can confidently signpost to patients looking to manage their cholesterol through diet.
Find out more https://t.co/0dxpLdv7KV
#CholesterolSmartLiving
🗣️Meet our speaker
Registered Dietitian & Dietetic Adviser at @heartukcharity, Lynne translates evidence on diet, cholesterol & lipids into practical advice for healthcare professionals.
Find out more & join her workshop at this year’s #SHARPSLF2026 mtg
https://t.co/PacrxPNzJA
Today is #FHAwarenessDay! Marking the occasion, HEART UK is publishing The Economic Value of Detecting and Treating Familial Hypercholesterolaemia in the UK.
Familial hypercholesterolaemia (FH) is one of the most common inherited conditions linked to premature cardiovascular disease, yet it remains significantly underdiagnosed and undertreated.
HEART UK is calling for investment to optimise and expand FH cascade testing now, alongside consideration of FH within future newborn screening programmes.
Read the full report https://t.co/ftRzLYlOI2
#findfh
HEART UK advocates for people living with elevated cholesterol, including inherited high cholesterol, and who are at risk of or living with cardiovascular disease (CVD). Our Policy and Public Affairs work is important as we seek to influence government policy, the health and social care system, and public health. We do this to improve patient outcomes and to ensure that the prevention of CVD is central to health policy.
Find out more about HEART UK's Policy and Public Affairs work: https://t.co/8cISEnoqJ4
HEART UK's next Lipid Intelligence Network Meeting takes place on Tuesday 15th September at 1 pm
The Lipid Intelligence Network is a free virtual meeting helping bring together healthcare professionals with an interest in blood lipids.
These meetings provide an open forum to discuss any challenges you are facing with other health professionals working nationwide, helping to find practical solutions.
Register your place now: https://t.co/5JGlUTuzqG
Cardiovascular Health: A Vital Focus in Menopause Care
Although CVD onset generally occurs 7-10 years later in women than men, the cardiovascular risks associated with menopause go beyond those of normal ageing, underscoring the need for menopause-specific risk management.
This HCP blog explores how menopausal changes impact CVD risk and why this focus is essential for women's long-term health.
https://t.co/XpMe7jxSRB
@NHSEngland HEART UK is proud to have been a partner in this innovative project to increase cholesterol checks through community pharmacies. We look forward to the next stage of this exciting public health opportunity.
HEART UK is proud to have been a partner in this innovative project to increase cholesterol checks through community pharmacies.
It’s just been announced at the European Society of Cardiology congress that the project will be rolled out to a further 100 NHS pharmacies this autumn.
HEART UK looks forward to the next stage of this exciting public health opportunity.
https://t.co/CaHuRCR18o
Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD
This is a summary of national guidance for lipid management for primary and secondary prevention of cardiovascular disease (CVD). The pathway has been updated to include changes to NICE Guidance 238 (formerly CG181) - Cardiovascular disease, risk assessment and reduction, including lipid modification, which was published in December 2023,. The pathway also includes summaries from NICE CG71 NICE CG189, JBS3 and NICE technology appraisals for lipid-lowering medication.
https://t.co/8CSLl0U9EW
#lipids
Are you involved in the care of patients with familial hypercholesterolaemia (FH)?
We are seeking responses from clinicians across the UK to help understand current FH service capacity and the potential impact of identifying more individuals with FH through genomic testing.
Please complete the survey by 4th September, and share it with colleagues involved in FH care, including those working in lipid clinics, cardiology, genetics, paediatrics, primary care, and related specialities. A broad range of perspectives will help ensure the findings accurately reflect current practice across the UK.
https://t.co/qBGCKL25LD
@PCCS_UK 9th Annual Conference – New Frontiers in Cardiovascular Care takes place virtually on Thursday, 24th & Friday, 25th September 2026.
➡️ Find out more - https://t.co/dseCx6ZADl
This conference was developed by the PCCS and is intended for UK practising healthcare professionals only. Sponsors, which include pharmaceutical companies, have contributed financial support towards this event but have had no input in the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of sponsors can be found here - https://t.co/gg9QVysfAT